Articles tagged with Covid 19 Vaccines
Researchers found that SARS-CoV-2 mRNA vaccination produces a robust immune response in the nasal cavity, with higher levels of antibodies promoting neutralization. The study suggests targeting the S2 region for intranasal vaccines may increase nasal mucosal levels of IgA and viral neutralization.
Scientists at the University of Cambridge identified a signature in the blood that could predict how well an individual responds to vaccines. They found that those with higher levels of age-associated B cells are less effective after vaccination.
Researchers found that patients with persistent symptoms of long COVID experienced sustained inflammation and abnormal immune responses. However, after receiving a vaccine dose 12-16 months post-infection, these markers recovered to levels comparable to healthy vaccinated individuals.
Researchers at the University of Queensland have uncovered the atomic structure of the Langya virus, a highly infectious virus with pandemic potential. The study aims to develop broad-spectrum human vaccines and treatments for Henipaviruses, which cause severe disease and have the potential to get out of control.
A Singapore study found that COVID-19 vaccination remained effective against Omicron BA.4/BA.5 and XBB infections in children and adolescents. Vaccination before the first infection provided the highest immunity, with protection levels reaching up to 85.3%.
The BCG vaccine, primarily developed to prevent tuberculosis, was found ineffective against COVID-19 in a large international trial involving nearly 4,000 healthcare workers. Researchers discovered that vaccination increased the risk of symptomatic disease during the first six months following enrolment.
A study of 17,000 people across eight African countries found a decline in vaccine confidence, particularly for COVID-19 vaccines. The drop in routine childhood vaccinations has led to six million fewer children receiving life-saving shots, putting decades of progress at risk.
A large and diverse group of young children receiving mRNA COVID-19 vaccines found no indications of serious side effects. The study analyzed medical records for 23 serious potential side effects and found no safety concern for seizures or other outcomes.
A study by University of Missouri researchers found similarities in COVID-19 mortality rates between certain US states and Canadian provinces, highlighting the importance of localized public health strategies. The findings suggest that factors such as population density, age, and socioeconomic conditions may have contributed to these s...
Researchers have developed a color-changing material that can detect when medications get too warm, with tunable melting points to track temperatures from -94 to +99 degrees Fahrenheit. This innovative system has the potential to reduce electronic waste and improve medical cold supply chains.
Researchers found that boosting vaccine use can reduce lockdown intensity and duration, but the relationship varies based on factors like disease severity and vaccination speed. The study suggests a nuanced approach to balancing lockdowns and vaccinations in future pandemics.
A nationwide study of nearly 10,000 adults identifies 12 hallmarks of long COVID, including debilitating fatigue, loss of smell or taste, and gastrointestinal symptoms. The findings provide a new scoring system for clinicians to define and investigate treatments for patients with long COVID.
Researchers analyzed hospitalization and fatality rates of SARS-CoV-2 infection in England between May 2020 and March 2022. The study found that the mass vaccination campaign significantly reduced severe effects of the virus, with notable improvements after the emergence of Alpha, Delta, and Omicron variants.
The Vaccine Adverse Event Reporting System (VAERS) collects reports of adverse events after vaccination, but public confusion about its nature and reports has increased. A new report recommends renaming the system to a clearer alternative and making additional changes to reduce misinterpretation.
A comprehensive multicontinental analysis found that COVID-19 vaccination reduced mortality by 22% among hospitalized and oxygen-dependent individuals. Vaccination was particularly beneficial for vulnerable groups, such as the elderly and those with pre-existing conditions.
A new review of published research finds that vaccine hesitancy among parents is a persistent issue, with concerns about childhood vaccines persisting over time. The study highlights significant disparities in vaccination rates across states and demographic groups, including lower rates among Black and Hispanic children.
A recent study published in JAMA Pediatrics monitored the safety of Pfizer-BioNTech COVID-19 vaccine in over 3 million children, identifying only rare cases of myocarditis or pericarditis, consistent with previous reports. The results provide additional evidence supporting the safety of COVID-19 vaccines in children ages 5 to 17.
A survey study found that fewer than 1 in 10 vaccinated individuals received an incentive, with most reporting no change in their decision to get vaccinated. The study suggests that policy efforts to incentivize vaccination may be ineffective.
A large case-control surveillance study of over 100,000 pregnancies found COVID-19 booster vaccination not associated with spontaneous abortion. The results support the safety of COVID-19 booster vaccination recommendations for pregnant populations.
A decision analytical model found that increased uptake of bivalent booster vaccination among eligible age groups decreased pediatric hospitalizations and school absenteeism. The benefits of booster campaigns for children may be substantial, suggesting a focus on younger populations is crucial.
Researchers analyzed data from over 100,000 pregnancies and found no association between COVID-19 booster vaccination and increased miscarriage risk. The study adds to the growing understanding of the safety of COVID-19 booster vaccinations during early pregnancy.
A recent study found that COVID-19 infection can lead to increased infarct growth and ongoing tissue consumption even after successful reperfusion through angiography. This suggests a potentially aggressive clinical course for patients with COVID-19 and large-vessel occlusion acute ischemic stroke.
The study found that supplementing COVID-19 claims records with Immunization Information Systems vaccination data increased vaccinated individual numbers, yet potential under-recording remained. Improving reporting to Immunization Information Systems could enable frequent updates of vaccination status for all individuals and vaccines.
A new study investigates lockdowns and vaccines' complementary or substitutive roles in mitigating COVID-19's effects. The researchers found that vaccinations should be relaxed after substantial vaccination rates, but vastly different policies may be optimal depending on parameters.
A large, prospective study led by the Fred Hutchinson Cancer Center recommends that cancer patients receive SARS-CoV-2 mRNA vaccination three to four months after bone marrow transplant. The study found that early vaccination can provide crucial protection against severe COVID-19 in this vulnerable population.
Researchers found that people with severe obesity have a higher risk of severe COVID-19 outcomes and may need more frequent booster doses. Immunity declines faster in obese individuals, putting them at greater risk of infection over time.
MIT chemists develop rapid test to determine whether individuals have neutralizing antibodies against Covid-19, offering protection against future infections. The technique uses a fingerprint of sugar molecules to identify neutralizing antibodies in blood samples.
A new University of Ottawa study found that educated Black individuals in Canada were hesitant to receive the COVID-19 vaccine due to distrust in the healthcare network. The survey revealed that health literacy and racial discrimination played a significant role in this mistrust.
Researchers found that Fiocruz's partnership with AstraZeneca was crucial to the success of COVID-19 vaccine production in Brazil. The partnership demonstrated the importance of technology transfer agreements, regulatory support, and political skill. Bio-Manguinhos facility played a significant role in producing vaccines, making over 5...
A new COVID-19 vaccine developed at Rutgers University may provide more durable protection against SARS-CoV-2 and its emerging variants than existing vaccines. The vaccine, dubbed MT-001, uses a unique section of the spike protein as its immunogen, which could potentially elicit broadly neutralizing antibodies.
A study from Ann & Robert H Lurie Children's Hospital of Chicago found that the 'trusted parents' and 'safe and tested' message types increased Black parents' intentions to vaccinate their children. Messages emphasizing vaccine safety and efficacy were effective in addressing concerns among hesitant parents.
Researchers identified the immune signature of heart inflammation cases linked to mRNA vaccines, finding it caused by a generalized immune response rather than antibodies created by the vaccine. This knowledge may enable optimizing mRNA vaccines and reducing the risk of myocarditis in vaccinated individuals.
A study found that declines in racial disparities in COVID-19 mortality rates were largely due to increases in mortality among White individuals, rather than decreases in non-Hispanic Black and Hispanic populations. The shift from urban to rural areas also contributed to the decline.
A Swedish study of nearly 3 million women found weak and inconsistent associations between COVID-19 vaccination and contact with healthcare for postmenopausal bleeding. However, the researchers suggest that a causal effect is unlikely due to the limitations of self-reporting data.
The study found that COVID-19 vaccine-induced immunity rapidly declines after primary vaccination and booster doses, leading to a decrease in protection against Omicron and Delta infections. The results highlight the need for targeted vaccination strategies to combat the evolving SARS-CoV-2 virus.
Researchers from Baidu Research have developed an AI algorithm, LinearDesign, that boosts COVID-19 mRNA vaccine antibody response by 128-fold. The algorithm takes a mere 11 minutes to generate the most stable mRNA sequence encoding Spike protein.
A study found that psychological factors, such as beliefs and attitude towards the COVID-19 vaccine, significantly contribute to the onset and severity of adverse effects. The researchers investigated how fear, trust, and expectations affect side effects and explained 30% of the intensity of symptoms.
Researchers at the University of Missouri identified occludin protein as a mediator for cell-to-cell transmission of coronavirus. The study found that damaged occludin protein enables virus replication and spread to neighboring cells, worsening symptoms.
Researchers have identified mechanisms behind the emergence of new and contagious coronavirus variants by analyzing over three million genome sequences. The study found that concordant substitutions occurring at other sites influence the likelihood of a substitution occurring at a specific site, leading to unexpected variant emergence.
A world-leading international trial has found that the BCG vaccine does not protect healthcare workers against COVID-19, despite boosting 'front-line' immunity in infants and protecting against respiratory infections. The research involved 3988 healthcare workers and showed a higher risk of symptomatic COVID-19 in the BCG group.
The NVX-CoV2373 vaccine demonstrated strong safety and immunogenicity profiles in a clinical trial of over 2,200 adolescents. The study found the vaccine to be efficacious in preventing COVID-19, including the Delta variant.
A new study by Cedars-Sinai Medical Center finds that people with long COVID-19 produce higher levels of antibodies against the virus than those without. The elevated antibody levels persist for months longer than expected after receiving a COVID-19 vaccine, sparking further research into the condition.
Researchers discovered a 'cocktail' of human antibodies that show promise in fighting severe SARS-CoV-2 infections, including Omicron variants. The study revealed how the original Moderna vaccine could prompt the body to produce these broad-spectrum antibodies.
A Brazilian study analyzed data from over 40,000 patients admitted to ICUs and found lower mortality rates during the Omicron outbreak compared to previous strains of Covid-19. Vaccination coverage contributed to the lower mortality observed in the Omicron period, but vulnerable patients remain at risk.
Researchers at MIT have created a vaccine printer that can produce hundreds of vaccine doses in a day, using microneedle patches that can be stored long-term at room temperature. The printer can be deployed anywhere vaccines are needed, providing on-demand vaccine production.
A recent study found that 45% of parents believe the vaccine's long-term risks outweigh the benefits, while 18% fear being held responsible if their child gets sick after vaccination. To boost child vaccination rates, experts suggest addressing parental perceptions and increasing transparency.
A large-scale registry study in Finland identified factors associated with COVID-19 vaccination uptake, including low labor income and mental health issues. The study found that individuals in vulnerable positions were the least likely to vaccinate, highlighting the need for targeted vaccination campaigns.
A study published in Communications Biology suggests that gut bacteria's digestion of fucose sugar may be behind weaker immune responses to the COVID-19 mRNA vaccine. Individuals with lower T-cell responses had higher expression of genes FOS and ATF3, which are part of a larger group controlling T-cell survival and activity.
A study of 55,000 Canadian patients with COVID-19 found that vaccination significantly reduced severe outcomes and burden on healthcare systems. The research also highlights the importance of vaccination in reducing mortality rates associated with COVID-19.
Focusing public health messages on protecting oneself versus others has a significant impact on vaccination rates. A study found that messages emphasizing protection of one's community led to higher odds of COVID-19 vaccination than those focused on personal protection.
Researchers found that removing ovaries during a benign hysterectomy increases the risk of hospitalization for cardiovascular disease in premenopausal women, but not necessarily for cancer. The study supports current recommendations to conserve ovaries in premenopausal patients at low risk for ovarian cancer.
New research shows that COVID-19 vaccines have directly saved at least 1,004,927 lives across Europe between December 2020 and March 2023. The majority of these lives were saved in people aged 60 years and older, with the first booster accounting for almost two-thirds of lives saved.
The primary COVID-19 vaccines provided adequate protection against transmission, hospitalization, and death, but their effectiveness waned in the face of the Omicron variant. The study found that vaccines developed prior to Omicron's emergence were 83% effective against infection at baseline, but this decreased to 47% by 40 weeks.
Researchers found bivalent boosters to be 67% effective in preventing hospitalization and death, with effectiveness waning after four weeks. The boosters also reduced the risk of infection and death against newer omicron strains.
A new study found that the Pfizer bivalent COVID-19 booster vaccine reduced hospitalization and death risks by 72% and 68%, respectively, in adults aged 65 years and older. The study highlights the importance of bivalent booster vaccination in high-risk populations.
A new AI-generated vaccine targeting T-cells provides broad coverage against future COVID-19 variants, potentially lasting longer than current antibody-based vaccines. This innovation has the potential to be used for seasonal flu and other vaccines, offering a long-lasting solution to emerging viral diseases.
Researchers recognize the need for improved COVID-19 vaccines to prevent transmission and infection. Mucosal vaccines targeting the respiratory tract could be effective in blocking SARS-CoV-2 transmission and reducing disease burden.
A large study of over 3 million patients receiving the mRNA COVID-19 vaccine found extremely rare cases of retinal vascular occlusion. The researchers concluded that there is no evidence suggesting an association between the vaccine and newly diagnosed RVO, rates similar to those of other vaccinations.
A global study of 9,555 individuals found a 4% increase in heavy bleeding days and total bleeding quantity after COVID-19 vaccination. Changes often resolve by the first post-vaccination menstrual cycle.
A multi-state study confirms the Pfizer-BioNTech mRNA COVID-19 vaccine's effectiveness in children and adolescents against moderate and severe COVID-19 outcomes. The study found that vaccination provided significant protection, but effectiveness decreased during Omicron dominance, with a booster dose increasing protection.